Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)
Authors: O’Donnell Martin J. , McQueen Matthew , Sniderman Allan , Pare Guillaume , Wang Xingyu , Hankey Graeme J. , Rangarajan Sumathy , Chin Siu Lim , Rao-Melacini Purnima , Ferguson John , Xavier Denis , Lisheng Liu , Zhang Hongye , Pais Prem , Lopez-Jaramillo Patricio , Damasceno Albertino , Langhorne Peter , Rosengren Annika , Dans Antonio L. , Elsayed Ahmed , Avezum Alvaro , Mondo Charles , Judge Conor , Diener Hans-Christoph , Ryglewicz Danuta , Czlonkowska Anna , Pogosova Nana , Weimar Christian , Iqbal Romana , Diaz Rafael , Yusoff Khalid , Yusufali Afzalhussein , Oguz Aytekin , Penaherrera Ernesto , Lanas Fernando , Ogah Okechukwu S. , Ogunniyi Adesola , Iversen Helle K. , Malaga German , Rumboldt Zvonko , Oveisgharan Shahram , Al Hussain Fawaz , Nilanont Yongchai , Yusuf Salim ,   on Behalf of the INTERSTROKE Investigators
Published: June 2022

Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which may be due to differing associations within etiological stroke subtypes. We sought to determine the association of lipoproteins and apolipoproteins within stroke subtypes.Methods Standardized incident case-control STROKE study in 32 countries. Cases were patients with acute hospitalized first stroke, and matched by age, sex and site to controls. Concentrations of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (apoA1), and apoB were measured. Non-HDL-C was calculated. We estimated multivariable odds ratio (OR) and population attributable risk percentage (PAR%). Outcome measures were all stroke, ischemic stroke (and subtypes), and intracerebral hemorrhage (ICH).Results Our analysis included 11,898 matched case-control pairs; 77.3% with ischemic stroke and 22.7% with ICH. Increasing apoB (OR, 1.10; 95% confidence interval [CI], 1.06 to 1.14 per standard deviation [SD]) and LDL-C (OR, 1.06; 95% CI, 1.02 to 1.10 per SD) were associated with an increase in risk of ischemic stroke, but a reduced risk of ICH. Increased apoB was significantly associated with large vessel stroke (PAR 13.4%; 95% CI, 5.6 to 28.4) and stroke of undetermined cause. Higher HDL-C (OR, 0.75; 95% CI, 0.72 to 0.78 per SD) and apoA1 (OR, 0.63; 95% CI, 0.61 to 0.66 per SD) were associated with ischemic stroke (and subtypes). While increasing HDL-C was associated with an increased risk of ICH (OR, 1.20; 95% CI, 1.14 to 1.27 per SD), apoA1 was associated with a reduced risk (OR, 0.80; 95% CI, 0.75 to 0.85 per SD). ApoB/A1 (OR, 1.38; 95% CI, 1.32 to 1.44 per SD) had a stronger magnitude of association than the ratio of LDL-C/HDL-C (OR, 1.26; 95% CI, 1.21 to 1.31 per SD) with ischemic stroke (P<0.0001). Conclusions The pattern and magnitude of association of lipoproteins and apolipoproteins with stroke varies by etiological stroke subtype. While the directions of association for LDL, HDL, and apoB were opposing for ischemic stroke and ICH, apoA1 was associated with a reduction in both ischemic stroke and ICH. The ratio of apoB/A1 was the best lipid predictor of ischemic stroke risk.